ClinicalThought

Share

Program Content

Activities

  • IAS 2023 Introduction
    IAS 2023: My Thoughts on Key Presentations Anticipated in Brisbane
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 21, 2023

  • IAS 2023 Australia
    Australian Perspectives on Weight and Cardiometabolic Abnormalities From IAS 2023
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 10, 2023

  • Integrated HIV Care
    Integrated HIV Care as a Global Care Model: Implications for Canada
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 17, 2023

  • REPRIEVE Mexico
    Statins in HIV? Applying the Results of the REPRIEVE Trial to My Patients Living With HIV in Mexico
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 17, 2023

  • IAS 2023 Eastern Europe
    Key Takeaways From IAS 2023 on Diagnosis, Linkage to Care, and Treatment of Migrant and Refugee Populations in Eastern Europe
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 31, 2023

  • IAS 2023 Africa
    The Wait Is On: Anticipating the Uses of Long-Acting ART and PrEP in Africa
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 06, 2023

  • LA ART Adherence
    Long-Acting Antiretrovirals: A Strategy to Support Adherence in Those With Complex Medical and Social Issues?
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 06, 2023

  • Integrated Care Asia
    HIV and Cardiovascular Diseases in Asia: Can Integrated Healthcare Provide a Better Management Model?
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 12, 2023

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP, ViiV Healthcare

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

ViiV Healthcare

Partners

IAS 2023

ProCE Banner